AHR and acute myeloid leukemia: Scoville et al. further described the NK cell differentiation block in AML patients, with a mechanism highlighting a direct role of the transcription factor, the aryl hydrocarbon receptor (AHR), secreted from AML blasts (likely via exosomes) that was reversible with AHR inhibition [92].